BioCryst Pharmaceuticals News

News on BioCryst Pharmaceuticals (Ticker: BCRX) continually updated from thousands of sources around the net.

Friday Jun 7 | BayStreet.ca

StockCall Early Morning Insight into AFFY, AMGN, PDLI, QCOR, and BCRX ...

StockCall.com Provides Stock Research on Affymax Inc., Amgen Inc., PDL BioPharma Inc., Questcor Pharmaceuticals Inc., and BioCryst Pharmaceuticals Inc. Last year, patents on several blockbuster drugs expired, leading to increasing competition from generic drug makers.

Comment?

Tue May 28, 2013

P&T Community

Deadly H7N9 Bird Flu May Resist Tamiflu Vaccine

In an article published online in The Lancet , doctors in Shanghai and Hong Kong report that the deadly H7N9 avian influenza virus, which has claimed 39 lives, may be resistant to the widely used Tamiflu vaccine.

Comment?

Thu May 09, 2013

BioSpace

Biocryst Pharmaceuticals to Present at Two Upcoming Investor Conferences

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! BioCryst Pharmaceuticals, Inc.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry